exenatide has been researched along with zopiclone* in 2 studies
2 other study(ies) available for exenatide and zopiclone
Article | Year |
---|---|
New drugs 06, part I.
Topics: Acamprosate; Adenine Nucleotides; Alcohol Deterrents; Amyloid; Analgesics, Non-Narcotic; Anti-HIV Agents; Antifungal Agents; Antineoplastic Agents; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Benzofurans; Clofarabine; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Exenatide; Fibroblast Growth Factor 7; Guanine; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Lipopeptides; Lipoproteins; Macular Degeneration; Micafungin; omega-Conotoxins; Patient Education as Topic; Peptides; Peptides, Cyclic; Piperazines; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Stomatitis; Taurine; Tetrahydroisoquinolines; Urinary Incontinence; Venoms | 2006 |
Practical considerations of new drugs: new choices for old problems.
As drug therapy experts, pharmacists are often called upon for facts and opinions about recently introduced drugs. New drugs are introduced at a rate that exceeds the reading time of many busy practitioners. This article is intended to provide an objective information and broad-based discussion about new drug options that have particular relevance for the elderly. Drugs that will be reviewed include: acamprosate, darifenacin, eszopiclone, exenatide, ibandronate, nitazoxanide, pramlintide, pregabalin, ramelteon, tigecycline, tinidazole, trospium, and solifenacin. Topics: Advertising; Aged; Amyloid; Analgesics; Anti-Bacterial Agents; Azabicyclo Compounds; Clinical Trials as Topic; Drug Labeling; Exenatide; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Hypoglycemic Agents; Indenes; Islet Amyloid Polypeptide; Minocycline; Peptides; Piperazines; Pregabalin; Tigecycline; Venoms | 2006 |